Arun Sanyal, MD, MBBS

Arun J. Sanyal, MD, is Professor of Medicine, Division of Gastroenterology, Hepatology & Nutrition, and Executive Director of Education Core Center for Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. He received his MBBS from Maulana Azad Medical College of Delhi University, India and MD from the All India
Institute of Medical Sciences in New Delhi. Dr Sanyal completed his internal medicine residency at Texas Tech University Health Sciences Center, Amarillo, Texas, and a fellowship in gastroenterology and hepatology at the Virginia Commonwealth University, where he has remained on the faculty as a professor and clinician. Over the past 10 years, Dr Sanyal's research interests have focused on clinical studies nonalcoholic fatty liver disease (NAFLD), the role of the microbiome in NAFLD and nonalcoholic steatohepatitis (NASH), and the development of effective therapy for NASH, among other areas. He has authored or coauthored more than 200 articles and multiple book chapters. He has served on the editorial boards for American Journal of Gastroenterology, Gut and Hepatology and has been an associate editor for the therapeutic recommendations section of The Gastroenterologist, Journal of Clinical Gastroenterology, and Liver International. Dr Sanyal was involved in the development of the American College of Gastroenterology (ACG) and the American Association for the Study of Liver Diseases (AASLD) guidelines on the management of variceal hemorrhage, and the AASLD practice guidelines on NAFLD. His research over the past 20 years has been funded primarily by major grants from the National Institutes of Health (NIH).
Dr Sanyal is past president (2010) and secretary (2001-2003) of the AASLD and is active in numerous professional organizations. He was past chair of the Global Task Force for Liver Diseases of the AASLD, the European Association for the Study of the Liver, the Asian Pacific Association for the Study of the Liver, the Latin American Association for the Study of the Liver, and the African Association for Study of Liver Diseases. Dr Sanyal currently serves as Chair of the steering committee for the NIH nonalcoholic steatohepatitis clinical research network and the recently completed his tenure as the chair ofthe NIH hepatobiliary pathophysiology study section. He is a founding member of the American Board of Internal Medicine in Liver Disease. He is also on the scientific advisory board for Yale Liver Center. He is also the founder of the Liver Forum which is focused on regulatory science in liver disease.